Bloomberg's Goyal, Clavis's Chaudhury: Amazon Prime Day (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Poonam Goyal, Senior Retail Analyst for Bloomberg Intelligence, and Supriya Chaudhury, CMO for Clavis Insight, on the e-commerce per...
12 Jul 20168min
Bloomberg's Wilson on Winners, Losers, Stock of the Day (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Bloomberg stocks editor David Wilson on today's market winners, losers, and Stock of the Day: Belmond (BEL).See omnystudio.com/liste...
12 Jul 201612min
RBC's Golub Favors US Equities In Low Vol Environment (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Jonathan Golub, Chief US Market Strategist for RBC Capital Markets, on the markets, earnings, and why the call for lower returns on ...
12 Jul 201611min
Conference Board's Maselli on European Labor Markets (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Ilaria Maselli, Senior Economist, Europe, at the Conference Board, on the labor markets and future of employment of Europe.See omnys...
12 Jul 201611min
Bloomberg's Larson: Why Tech Companies Get Sued in China(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. Guest: Matt Larson, Litigation Analyst for Bloomberg Intelligence, on why tech companies are getting sued in China.See omnystudio.com/liste...
12 Jul 20168min
John Sculley Sees $10 Billion in Revenues for RxAdvance (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Former Apple and Pepsi CEO John Sculley on his current entrepreneurial endeavors in healthcare, and the strategies outlined in his n...
12 Jul 201611min
Pemberton's Durcikova: Investing in Toronto Real Estate (Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Mariana Durcikova, Broker at Pemberton Group, on the benefits to investing in Toronto real estate, compared to NYC.See omnystudio.co...
12 Jul 201611min
Shire's Ornskov on $1 Billion Potential for Dry-Eye Drug(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Shire CEO Flemming Ornskov on the outlook for the company after getting FDA approval for Xiidra drops to treat dry-eye disease.See o...
12 Jul 20168min
